The production of biopharmaceuticals is more complex than that of chemical medicines. The production process is influenced by various factors such as choice of cell lines, harvesting, purification and the further treatment to the finished product. At present, fed-batch is the most preferred process used in the manufacture of biopharmaceuticals. However, in the future, the industry is likely to witness greater adoption of continuous processes to improve scalability and facilitate time-to-market -at the same time – lowering capital and operating costs. Further, there is a change in the trend from use of stainless-steel-based equipment to disposable/single-use technology-based equipment to save capital investment and achieve operational flexibility. “Meticulous Research” in its latest publication states that, the “global market for biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 14.8% from 2017 to 2023 to reach $22,340.0 million by 2023.”
This growth is primarily driven by the growing demand for biopharmaceuticals, capacity expansion from biopharmaceutical manufacturers, rising adoption of single-use products, and increase in the support from government for biopharmaceutical research.
Biopharmaceutical Processing Equipment And Consumables Market By Product (Filtration, Chromatography, Columns, Bioreactor, Cell Culture, Service), Application (Commercial, Research), And End User (Pharmaceutical, Biotechnology, CDMO)- Global Forecast To 2023
Don’t miss out on business opportunities @ Biopharmaceutical Processing Equipment And Consumables Market
The prevalence of cancer, autoimmune, cardiovascular, and infectious diseases is growing across the globe. Biopharmaceuticals have emerged as an important therapeutic class for treatment of such diseases. Biopharmaceuticals have many advantages over synthetic drugs. These products target specific sites and rarely cause side effects – often observed with synthetic/conventional drugs. Biopharmaceuticals offer high specificity and activity. They have enabled the treatment of patients who does not respond/poorly respond to the traditional synthetic drugs. Owing to this, demand for biopharmaceuticals such as vaccines, therapeutic proteins, and antibodies is growing day by day.
Since 2000, biopharmaceuticals have exhibited substantial growth in the overall pharmaceutical market. Over the last 8-10 years, the biopharmaceutical market has grown at a CAGR of ~11% and at present, they represent ~25% share in overall pharmaceutical market. At present, antibody-based biopharmaceuticals have dominance in the market. Further, there is large number of antibody-based biopharmaceuticals present in the pipeline of various biopharmaceutical companies. According to American Pharmaceutical Review – one of the leading journal in the pharmaceutical industry – the percentage of antibody-based products currently under the biologic license application (BLA) or equivalent stage of regulatory submission – accounts for ~67% of all biopharmaceuticals. According to the journal, they contribute ~82% of products in phase 3 development and ~90% of products in phase 1 and 2 development. As more and more of such biopharmaceuticals enter commercial stage, it will subsequently lead to growth in demand for bioprocessing equipment and consumables used in their production.
The report provides meticulous analysis of biopharmaceutical processing equipment and consumables market on the basis of product (filtration, chromatography, columns, bioreactor, cell culture, service), application (commercial, research), and end user (pharmaceutical, biotechnology, CDMO), and geography.
Rising Adoption of Single-Use Bioprocessing Equipment and Consumables
Capacity Expansions from Biopharmaceutical Manufacturers
Increase in the Support from Governments for Biopharmaceutical Research
Complex Development and Manufacturing Process of Biopharmaceuticals
Obstacles in Raising Funding for Early-Stage Biopharmaceutical Start-Ups
Significant Opportunities from Emerging Asia-Pacific and Latin American Market
Expected Surge In Biosimilar Production In the U.S.
Personalized Medicine to Offer New Growth Avenues
Intensive Capital Requirements in Biopharmaceutical Production
Concerns Regarding Stem Cell Research
Rising Focus on Continuous Bioprocessing
Use of Disposable Processing Equipment for Commercial Production
Download free sample report @ Biopharmaceutical Processing Equipment And Consumables Market Research
The key players analyzed in the biopharmaceutical processing equipment and consumables market are GE Healthcare (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), 3M Company (U.S.), Repligen Corporation (U.S.), Agilent Technologies, Inc. (U.S.), and Eppendorf AG (Germany).
Key Topics Covered in This Report:
- Research Methodology
- Executive Summary
- Market Share Analysis
- Market Insights
- Global Biopharmaceutical Processing Equipment and Consumables Market, By Product Type
- Global Biopharmaceutical Processing Equipment and Consumables Market, By Application
- Global Biopharmaceutical Processing Equipment and Consumables Market, By End User
- Geographic Analysis
- Competitive Landscape
- Company Profiles
Speak to Our Analyst and gain crucial industry insights that will help your business grow: